Number One e-Voting Platform Across The Globe Contact Us As We Are Here To Help. Customers Satisfaction You Are Highly Welcome To Squadlinq.com.ng!

You are welcome to Official squadlinq website! We highly appriciate your everyday visit to squadlinq.com.ng. Contact us: +2347019407440 +2348074071008, +17869030441, +234074071008. We are here to help

Researchers develop new system for effective cancer diagnosis and treatment

A research group consisting of scientists from NUST MISIS, the Technical University of Munich, Helmholtz Zentrum München, the University of Duisburg-Essen, and the University of Oldenburg has developed a system that allows doctors to both improve the accuracy of diagnosing malignant cells and to provide additional opportunities for cancer treatment. The magnetoferritin compound is the main element of this new system. The research article has been published in Advanced Functional Materials. The lack of accuracy ("contrast") in imaging is a common problem of non-invasive diagnosis. "Contrast agents", compounds that are introduced into the body before a diagnosis procedure to enhance the response and make affected cells more visible on a tomograph, can be used to solve this problem in magnetic resonance imaging (MRI). Paramagnetic gadolinium particles and superparamagnetic iron particles are among these agents. However, even in small quantities, these substances - alien to the human body - can potentially be dangerous. Magnetoferritin is a compound consisting of endogenous human protein (ferritin) and a magnetic nucleus. The development and testing of the compound was conducted following the existing protocol for the synthesis of magnetoferritin, but was improved for the effective capture of tumor cells. The high concentration of magnetoferritin in tumor tissue made it possible to obtain a hypoallergenic contrast agent that is perfectly compatible with the human body.
Thanks For You Reading The Post We are very happy for you to come to our site. Our Website Domain name http://www.squadlinq.com.ng/.
Newer Posts Newer Posts Older Posts Older Posts

More posts

Comments

Post a Comment